Infliximab for the treatment of rheumatoid arthritis.
BACKGROUND: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. OBJECTIVES: To assess the efficacy and safety of infliximab for the treatment of rheumatoid arthritis. SEARCH STRATEGY: Electronic databases...
主要な著者: | Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2002
|
類似資料
-
Etanercept for the treatment of rheumatoid arthritis.
著者:: Blumenauer, B, 等
出版事項: (2003) -
Etanercept for the treatment of rheumatoid arthritis
著者:: Blumenauer, B, 等
出版事項: (2004) -
Etanercept for the treatment of rheumatoid arthritis.
著者:: Lethaby, A, 等
出版事項: (2013) -
Infliximab in the treatment of rheumatoid arthritis
著者:: A Perdriger
出版事項: (2009-05-01) -
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
著者:: Jobanputra, P, 等
出版事項: (2002)